首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis
【2h】

Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis

机译:常见的可变免疫缺陷和补体系统;低甘露糖结合凝集素水平与支气管扩张有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The importance of the innate immune system, including mannose-binding lectin and the complement system, in common variable immunodeficiency is unclear. The objective of this study was to evaluate mannose-binding lectin and the complement system in relation to clinical and immunological parameters in patients with common variable immunodeficiency. Circulating levels of mannose-binding lectin, complement components, complement activation products and functional capacity of complement pathways were correlated to clinical features within 71 patients and compared with 30 healthy controls. The main findings were; the patients had signs of increased complement activation significantly associated with signs of autoimmunity and immunological hyperactivity; there were no signs of deficiencies of the classical and alternative complement pathways in the patient group; the prevalence of lectin pathway deficiency was the same in patients and controls, but patients with increased frequency of lower respiratory tract infections or bronchiectasis had lower capacity of the lectin pathway than patients without these features (P = 0·002 and 0·004, respectively); the serum concentration of mannose-binding lectin was inversely correlated to the frequency of lower respiratory tract infections (P = 0·002) and bronchiectasis (P = 0·01). We conclude that patients with common variable immunodeficiency have no increased frequency of complement deficiencies but signs of increased complement activation. Our findings suggest that mannose-binding lectin and the lectin complement pathway may protect against lower respiratory tract infection and bronhiectasis in patients with common variable immunodeficiency.
机译:目前尚不清楚先天免疫系统(包括甘露糖结合凝集素和补体系统)在常见的可变免疫缺陷中的重要性。这项研究的目的是评估常见免疫变异患者的甘露糖结合凝集素和补体系统与临床和免疫学参数的关系。甘露糖结合凝集素,补体成分,补体激活产物和补体途径功能的循环水平与71例患者的临床特征相关,并与30名健康对照者进行了比较。主要发现是:患者的补体激活增加的迹象与自身免疫和免疫功能亢进的迹象显着相关;患者组中没有经典和替代性补体途径不足的迹象;凝集素途径缺乏的患病率在患者和对照组中是相同的,但是下呼吸道感染或支气管扩张的频率增加的患者其凝集素途径的能力比没有这些特征的患者低(P分别为0·002和0·004) );血清甘露糖结合凝集素的浓度与下呼吸道感染的频率(P = 0·002)和支气管扩张(P = 0·01)呈负相关。我们得出的结论是,具有常见可变免疫缺陷的患者补体缺陷的频率没有增加,但是补体激活增加的迹象。我们的研究结果表明,甘露糖结合凝集素和凝集素补体途径可能在常见的可变免疫缺陷患者中预防下呼吸道感染和支气管扩张。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号